Press Release FeedGet the RSS feed
Menu

GlobeNewswire

Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients

GlobeNewswire

PARSIPPANY, N.J., Oct. 02, 2026 -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the Journal of Child Neurology published a comprehensive review examining dopamine pathways in Tourette syndrome and the therapeutic potential of ecopipam, a first-in-class investigational selective D1 (dopamine) receptor antagonist for the treatment of pediatric patients with Tourette syndrome.1,2 The review evaluates current treatment limitations and details how selectively targeting D1 receptors in the brain’s direct motor pathway may offer a differentiated, non-antipsychotic approach for managing tics in pediatric patients.1

  1. Stallion Power Gummies Releases 2026 Ingredient, Usage and Safety Details for Its Male Enhancement Formula in the US and CanadaStallion Power Male Enhancement Gummies Combine Muira Puama, Maca Root, Horny Goat Weed, L-Arginine, Tribulus Terrestris, Catuaba, Ashwagandha, Green Tea Extract and Caffeine in a Once-Daily Gummy for Adult Men
  2. CryptoU-topia Launches Public Beta as Global Builders Gather for U-HackathonFinancial technology company opens its app in more than 50 countries during FLOW Summit as 500-plus builders develop AI and Web3 products
  3. FinanceROSEN, SKILLED INVESTOR RIGHTS COUNSEL, Encourages AST SpaceMobile, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ASTSWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AST SpaceMobile, Inc. (NASDAQ: ASTS) between March 4, 2025 and July 15, 2026, inclusive (the “Class Period”), of the important November 13, 2026 lead plaintiff deadline.
  4. FinanceROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Baidu, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BIDUWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Baidu, Inc. (NASDAQ: BIDU) between November 18, 2025 and August 17, 2026, inclusive (the “Class Period”), of the important November 13, 2026 lead plaintiff deadline.
  5. FinanceBBNX DEADLINE: ROSEN, LEADING TRIAL COUNSEL, Encourages Beta Bionics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBNXWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Beta Bionics, Inc. (NASDAQ: BBNX) between July 30, 2025 and February 24, 2026, both dates inclusive (the “Class Period”), of the important November 3, 2026 lead plaintiff deadline.
  6. FinanceROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tigo Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - TYGOWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tigo Energy, Inc. (NASDAQ: TYGO) between February 24, 2026 and August 4, 2026, both dates inclusive (the “Class Period”), of the important November 23, 2026 lead plaintiff deadline in the securities class action first filed by the Firm.